These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3958371)

  • 21. [Clinical study of injectable amiodarone].
    Daubert JC; Gouffault J
    Coeur Med Interne; 1977; 16(3):415-21. PubMed ID: 336262
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
    Peter T; Hamer A; Mandel WJ; Weiss D
    Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term tolerance of amiodarone treatment for cardiac arrhythmias.
    Smith WM; Lubbe WF; Whitlock RM; Mercer J; Rutherford JD; Roche AH
    Am J Cardiol; 1986 Jun; 57(15):1288-93. PubMed ID: 3717027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amiodarone in subjects with pneumopathies].
    Scoditti S; Colella A; Campobasso M
    Arch Monaldi; 1984; 39(1-2):83-90. PubMed ID: 6532352
    [No Abstract]   [Full Text] [Related]  

  • 25. Long term efficacy of class I antiarrhythmic agents and amiodarone in patients with malignant ventricular arrhythmias.
    Schmidt G; Goedel-Meinen L; Jahns G; Linné R; Schaudig U; Kein G; Baedeker W; Wirtzfeld A
    Drugs; 1985 Mar; 29 Suppl 3():37-46. PubMed ID: 3996244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone--a new type of antiarrhythmic drug.
    Drug Ther Bull; 1981 Oct; 19(22):86-8. PubMed ID: 7285808
    [No Abstract]   [Full Text] [Related]  

  • 27. Once per week oral administration of amiodarone in the prophylaxis of supraventricular paroxysmal tachycardia.
    Padrini R; Inama G; Piovan D; Furlanello F
    Pharmacol Res Commun; 1985 Nov; 17(11):1043-52. PubMed ID: 4089009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Another type of interaction between blood levels of digitalis and anti-arrhythmic drugs: digoxin and amiodarone. Experience with long-term therapy].
    Furlanello F; Inama G; Ferrari M; Padrini R; Guarnerio M; Vergara G; Dal Forno P; Bettini R; Disertori M
    G Ital Cardiol; 1981; 11(11):1725-8. PubMed ID: 7343376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone: clinical consideration.
    Smith A
    Focus Crit Care; 1984 Oct; 11(5):30-7. PubMed ID: 6567551
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral flecainide for prophylaxis of paroxysmal atrial fibrillation.
    Chouty F; Coumel P
    Am J Cardiol; 1988 Aug; 62(6):35D-37D. PubMed ID: 3136633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Longterm effects of amiodarone in supraventricular tachyarrhythmias (author's transl)].
    Chadid P; Corbalán R; Fernández M; Luco C; Casanegra P
    Rev Med Chil; 1981 Apr; 109(4):318-23. PubMed ID: 7323518
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-arrhythmic properties of amiodarone. Clinical experience].
    Iannetti M; Pastorini C; Masperone MA; Caponnetto S
    Arch Maragliano Patol Clin; 1974; 30(2):251-5. PubMed ID: 4480712
    [No Abstract]   [Full Text] [Related]  

  • 34. [Amiodarone, a new anti-arrhythmia agent in arrhythmia associated with myocardial infarct].
    Watanabe Y; Katoh T
    Nihon Rinsho; 1983 Dec; 41(12):2766-70. PubMed ID: 6674562
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
    Tonet JL; Lechat P; Frank R; Lascault G; Fontaine G; Facquet J; Cohen A; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1984; 33(5):309-15. PubMed ID: 6476769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Amiodarone in the control of supraventricular tachyarrhythmias].
    Molina L; Heredia P; Pinto R; Mesa A; Villarreal A; Gutiérrez Fuster E
    Arch Inst Cardiol Mex; 1983; 53(1):13-6. PubMed ID: 6191726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amiodarone by intravenous route].
    Lotto A
    G Ital Cardiol; 1985 Mar; 15(3):298. PubMed ID: 4018469
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
    Stern H; Scheininger M; Theisen F; Theisen K
    Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.